Gelteq (GELS) Assets Average (2024 - 2025)

Gelteq (GELS) recorded quarterly Assets Average of $15.1 million in Q2 2025, little changed quarter-over-quarter from $15.1 million in Q4 2024, and up 5.1% on a YoY basis from $14.4 million in Q2 2024.

Gelteq (GELS) Assets Average (2024 - 2025) Analysis & Trends

Gelteq's Assets Average history runs 2 years deep, the most recent figure standing at $15.1 million for Q2 2025.

  • In Q2 2025, Assets Average rose 5.1% year-over-year to $15.1 million; the TTM figure through Jun 2025 stood at $15.1 million (up 5.1% YoY), while the FY2025 annual figure was $13.7 million, down 4.46% from the prior year.
  • Assets Average was $15.1 million for Q2 2025 at Gelteq, roughly flat from $15.1 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $15.1 million in Q2 2025 to a low of $14.4 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.39 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.32 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 7.30 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 552.96 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.77 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.29 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 3.37 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.21 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.29 Bn
10 Gelteq 10.57 Mn 10.34 Mn - 15.09 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 15.09 Mn
Dec 31, 2024 15.05 Mn
Jun 30, 2024 14.36 Mn